Menu
Back to Archived Journals » Core Evidence » Volume 9
Core Evidence ceased publishing in January 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Core Evidence
ISSN: 1555-175X
- View all (143)
- Volume 15, 2020 (4)
- Volume 14, 2019 (6)
- Volume 13, 2018 (3)
- Volume 12, 2017 (2)
- Volume 11, 2016 (5)
- Volume 10, 2015 (9)
- Volume 9, 2014 (13)
- Volume 8, 2013 (7)
- Volume 7, 2012 (12)
- Volume 6, 2011 (7)
- Volume 5, 2010 (9)
- Volume 4, 2009 (20)
- Volume 3, 2008 (5)
- Volume 2, 2007 (22)
- Volume 1-Issues 3 & 4, 2006 (8)
- Volume 1-Issues 1 & 2, 2005 (11)
Archive: Volume 9, 2014
Luliconazole for the treatment of fungal infections: an evidence-based review
Khanna D, Bharti S
Core Evidence 2014, 9:113-124
Published Date: 24 September 2014
Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy
Koerner-Rettberg C, Ballmann M
Core Evidence 2014, 9:99-112
Published Date: 19 September 2014
Brodalumab: an evidence-based review of its potential in the treatment of moderate-to-severe psoriasis
Coimbra S, Figueiredo A, Santos-Silva A
Core Evidence 2014, 9:89-97
Published Date: 21 July 2014
Regorafenib: an evidence-based review of its potential in patients with advanced liver cancer
Ravi S, Singal AK
Core Evidence 2014, 9:81-87
Published Date: 17 July 2014
Clinical utility of treprostinil in the treatment of pulmonary arterial hypertension: an evidence-based review
Buckley MS, Berry AJ, Kazem NH, Patel SA, Librodo PA
Core Evidence 2014, 9:71-80
Published Date: 20 June 2014
Development of cabozantinib for the treatment of prostate cancer [Corrigendum]
Vaishampayan UN
Core Evidence 2014, 9:69-70
Published Date: 16 May 2014
Development of cabozantinib for the treatment of prostate cancer
Vaishampayan UN
Core Evidence 2014, 9:61-67
Published Date: 23 April 2014
Ocriplasmin for symptomatic vitreomacular adhesion: an evidence-based review of its potential
Song SJ, Smiddy WE
Core Evidence 2014, 9:51-59
Published Date: 21 March 2014
Eptifibatide: The evidence for its role in the management of acute coronary syndromes [Corrigendum]
Shah I, Khan SO, Malhotra S, Fischell T
Core Evidence 2014, 9:49-50
Published Date: 14 March 2014
Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis
Di Franco M, Gerardi MC, Lucchino B, Conti F
Core Evidence 2014, 9:41-48
Published Date: 12 March 2014
Micafungin: an evidence-based review of its place in therapy
de la Torre P, Reboli AC
Core Evidence 2014, 9:27-39
Published Date: 25 February 2014
Ceftazidime–avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections
Lagacé-Wiens P, Walkty A, Karlowsky JA
Core Evidence 2014, 9:13-25
Published Date: 24 January 2014
Targeted therapy in triple-negative metastatic breast cancer: a systematic review and meta-analysis
Clark O, Botrel TE, Paladini L, Ferreira MB
Core Evidence 2014, 9:1-11
Published Date: 6 January 2014